Skip to main content

Barrett Esophagus

Daniel J. Stein, MPH, MD Reviewed 05/2023
 


BASICS

DESCRIPTION

  • Metaplasia of the distal esophageal mucosa from native stratified squamous epithelium to abnormal columnar (intestinalized) epithelium; likely a consequence of chronic GERD

  • Predispose...

DIAGNOSIS

HISTORY

  • Assess underlying risk factors.

  • Common GERD symptoms: heartburn, regurgitation

  • Atypical symptoms include chest pain, odynophagia, chronic cough, water brash, globus sensation, laryngiti...

TREATMENT

MEDICATION

  • The goal of medical therapy is to control GERD and reduce esophagitis.

  • Neither suppression of gastric acid production via high-dose PPIs nor reduction in esophageal acid exposure vi...

ONGOING CARE

FOLLOW-UP RECOMMENDATIONS

  • Surveillance is recommended in high-risk patients with histologically confirmed BE.

  • Surveillance intervals depend on grade of dysplasia.

  • Patients diagnosed with BE ...

REFERENCES

1
Muthusamy VR, Wani S, Gyawali CP, et al; CGIT Barrett’s Esophagus Consensus Conference Participants. AGA Clinical Practice Update on New Technology and Innovation for Surveillance and Scre...

ADDITIONAL READING

  • Sarem M, Martinez Cerezo FJ, Salvia Favieres ML, et al. Low-grade dysplasia in Barrett's esophagus: a problematic diagnosis. Gastroenterol Hepatol. 2022;S0210-5705(22)00228-x. doi: ...

CODES

ICD10

  • K22.70 Barrett’s esophagus without dysplasia

  • K22.719 Barrett’s esophagus with dysplasia, unspecified

  • K22.710 Barrett’s esophagus with low grade dysplasia

  • K22.711 Barrett’s esophagus with high ...

CLINICAL PEARLS

  • Patients with BE and no dysplasia can be managed with endoscopic surveillance. Patients with low-grade dysplasia may be managed with either endoscopic surveillance or endoscopic eradic...

Subscribe to Access Full Content

Sign Up for a 10-Day Free Trial

Sign up for a 10-day FREE Trial now and receive full access to all content.

 
×